Pharmacogenomics : social, ethical, and clinical dimensions /
"Pharmacogenomics promises to revolutionize medicine by enabling the prevention, diagnosis, and treatment of diseases at the genome level. While a substantial amount of public and private research focuses on new pharmacogenomic applications, notably less attention has been directed to the ethic...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Hoboken, N.J. :
Wiley-Liss,
c2003.
|
| Subjects: | |
| Online Access: | Publisher description Book review (E-STREAMS) Table of contents |
Table of Contents:
- Public attitudes about pharmacogenomics / Mark A. Rothstein and Carlton A. Hornung
- Pharmacogenomics: pharmacology and toxicology in the genomics era / Harvey W. Mohrenweiser
- The implications of population genetics for pharmacogenomics / Craig L. Hanis
- Genome research and minorities / Henry T. Greely
- Drug development strategies / Penelope K. Manasco and Teresa E. Arledge
- Drug development, regulation, and genetically guided therapy / David W. Feigal and Steven I. Gutman
- Intellectual property and commercial aspects of pharmacogenomics / Allen C. Nunnally, Scott A. Brown, and Gary A. Cohen
- Integration of pharmacogenomics into medical practice / Gilbert S. Omenn and Arno G. Motulsky
- Clinical utility of pharmacogenetics and pharmacogenomics / Neil A. Holtzman
- Medical liability for pharmacogenomics
- Larry I. Palmer
- The challenges of pharmacogenomics for pharmacy education / David B. Brushwood
- Economic implications of pharmacogenomics / C.E. Reeder and W. Michael Dickson
- Pharmacogenomics and the social construction of identity / Morris W. Foster
- Pharmacogenomics: considerations for communities of color / Laurie Nsiah-Jefferson
- Constitutional issues in the use of pharmacogenomic variations associated with race / John A. Robertson.